u/swirl_dont_shake

10mg into 3mL is 3.33mg/mL, and 2.5mg of that is 75 units

What concentration did you actually reconstitute at, rather than what did you intend to?

Which week did the appetite change actually land for you?

A 503A pharmacy compounds for an identified patient against a prescription. A 503B outsourcing facility registers with the regulator, may produce without patient-specific prescriptions, and is subject to current good manufacturing practice requirements. The two are governed differently and the difference is not cosmetic.

Small correction, said kindly: those are two different products with similar names, and the difference matters for a multi-draw vial.

Corrected the concentration in the title, which contradicted the body. Nothing else touched.

Do you have the paper, or a summary of it?

Do you have the paper, or a summary of it?

reship policy in writing before the order, not after

Yes — time in range tells you about variability, which the average deliberately hides.

Careful. "Nobody has tested Paradigm Peptide" is a statement about this board, not about the supplier. Say the first thing, not the second.

compounded is not generic, there is no equivalence claim

Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot.

Research-use-only material is not approved for human use, so treat everything in this thread as arithmetic about solutions rather than instructions for a person.

Same. I got this wrong once, caught it because the units looked absurd, and have written on every vial since.

Yes — median rather than best case.

annika_fonseca is right about regional stock. It changes the shape of the distribution, not just the mean.

if the price is impossible, the material is the thing being economised on

What week are you in?

Yes. Spread across lots is the number that tells you about the process. A single high result tells you about a vial.

Appetite effect for me is flat across seven days. On sema it was a wave. Same person, different molecule.

Has the appetite changed, even if the scale has not?

Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.

The directory deliberately separates "we have nothing on this name" from "this went badly". Collapsing the two is how boards like this generate false certainty.

Agreed. The clone copies the front page and never the paperwork, because the paperwork is the expensive part.

I would not panic about that. It is on the list of ordinary first-month experiences.

Left up and flaired Explainer — the numbers in this one check out.

Right, and the concentration genuinely can differ from the branded product, which breaks people’s arithmetic.

Gently disagree with the framing — nothing has gone wrong. Week 19 looking flat is the ordinary experience.

a mechanism you can state is not a mechanism you have demonstrated

2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.

tolerance to the gastric effect develops, appetite effect largely persists

How long between the two A1c measurements?

hypoglycaemia risk depends far more on what else you take

Variability dropped before the average did, which was visible on the sensor and invisible on the lab result.

Reminder: this board does maths, not dosing. Nobody here tells another member what amount to take.

Working has to be shown on arithmetic posts. Added a note asking for it rather than removing this one.

Long half-life in this class comes from structural modification that promotes albumin binding and resists enzymatic degradation. Weekly dosing is a consequence of the molecule, not a convenience decision.

Cosigning the four-week thing. It is a minimum interval, and treating it as a schedule to keep up with is how people end up miserable at 12.5.

503A or 503B — do you know which?

Did you come to this from sema, and if so how long was the gap?